Clinical Trial: A Pilot Intervention Study Using Markerless Motion Capture to Evaluate the Effects of Posture Walking on Gait Biomechanics and Pain in Women with Pelvic Girdle Pain (Japan)

Tokyo, Aug. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058715) titled 'Effect of Posture Walking Intervention on Gait Biomechanics in Women with Pelvic Girdle Pain' on Aug. 6.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Non-randomized Blinding - Open -but assessor(s) are blinded Control - No treatment

Primary Sponsor: Institute - Okayama university

Condition: Condition - Back pain/Pelvic girdle pain Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The first objective of this study is to evaluate and compare gait biomechanics between women with pelvic girdle pain (PGP) and healthy controls using markerless motion capture, in order to identify characteristic gait patterns associated with PGP. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Name: Posture Walking Training Target group: Women aged 18 to under 60 years with pelvic girdle pain (PGP) Description: A total of three posture walking sessions over two months Session 1: In-person (45 minutes at the measurement site) Sessions 2 and 3: Online via Zoom (45 minutes each) Interventions/Control_2 - control

Eligibility: Age-lower limit - 18 years-old = Gender - Female Key inclusion criteria - Participants must meet all of the following criteria:

Able to visit the measurement site at Okayama University Hospital by September 30, 2026

Able to provide written informed consent voluntarily

Female, aged 18 years or older and under 60 years at the time of consent

Body weight less than 100 kg

Able to walk independently without assistive devices such as canes or walkers

Capable of communicating in Japanese Key exclusion criteria - Participants who meet any of the following criteria will be excluded History of knee or hip surgery within the past 3 months Diagnosed with neuromuscular disorders such as Parkinsons disease or multiple sclerosis Currently pregnant History of pelvic, vertebral, or femoral fracture within the past 6 months Has physical pain requiring medical treatment History of myocardial infarction within the past 2 years Has moderate to severe heart disease, including aortic stenosis, acute pericarditis, aortic aneurysm, symptomatic angina, symptomatic valvular disease, untreated arrhythmias, or intermittent claudication Has uncontrolled atrial fibrillation History of stroke(cerebral infarction) within the past 2 years Respiratory dysfunction, including, Use of home oxygen therapy, Being treated for airway-obstructing conditions (e.g., thyroid tumor, metastatic tumor) Severe renal dysfunction (e.g., currently on dialysis) Resting systolic blood pressure >200 mmHg or diastolic blood pressure >100 mmHg Judged by the investigator to be inappropriate for study participation (e.g., insufficient understanding of the study, objection to study procedures, etc.) Target Size - 40

Recruitment Status: Recruitment status - No longer recruiting Date of protocol fixation - 2024 Year 08 Month 01 Day Date of IRB - 2024 Year 10 Month 22 Day Anticipated trial start date - 2024 Year 10 Month 24 Day Last follow-up date - 2025 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067114

Disclaimer: Curated by HT Syndication.